Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Alpha-Ketoglutarate Reverses Cartilage Damage in Osteoarthritis via Epigenetic ReprogrammingLongevity & Aging

Alpha-Ketoglutarate Reverses Cartilage Damage in Osteoarthritis via Epigenetic Reprogramming

Researchers at Tongji University discovered that osteoarthritis (OA) impairs glutamine metabolism in chondrocytes through epigenetic silencing of key transporter and enzyme genes. Alpha-ketoglutarate (αKG), a TCA cycle intermediate, countered this by activating the demethylase Kdm6b, which removed repressive H3K27me3 marks from glutaminolysis genes and the ubiquitin-ligase gene Ube2o. Elevated Ube2o then ubiquitinated TRAF6, suppressing NF-κB signaling and restoring metabolic balance. In both surgically induced and obesity-related mouse OA models, αKG supplementation significantly reduced cartilage degradation, establishing a TCA- and HIF-1α-independent therapeutic mechanism.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.